Siemens Healthineers AG (XTRA:SHL) is planning to exit its India-based cancer care chain American Oncology Institute in a transaction valued at around INR 15,000 million to INR 20,000 million, according to people familiar with the matter. The deal is being advised by investment firm Alvarez & Marsal, and several private equity funds have been approached as potential buyers. Listed oncology chain HealthCare Global Enterprises Limited (NSEI:HCG), backed by KKR, is also among the bidders being considered, sources said.
The proposed divestment is part of Siemens Healthineers? broader strategic review of its global healthcare portfolio. The development comes at a time when India?s cancer care sector is witnessing steady expansion, driven by rising incidence of cancer, increased diagnostic awareness, and growing demand for advanced treatment infrastructure.
The sector has also seen heightened interest from private equity investors and hospital chains seeking to expand oncology networks. If completed, the transaction would mark Siemens Healthineers? exit from direct ownership of a multi-country oncology hospital chain, while potentially reshaping the competitive landscape of organized cancer care in India.
The process is still in early stages, and the final valuation and ownership structure may evolve depending on negotiations with interested parties.
